Michael Bau Mortensen, Francesco Casella, Özgül Düzgün, Olivier Glehen, Peter Hewett, Martin Hübner, Magnus Skov Jørgensen, Alfred Königsrainer, Miguel Marin, Marc Pocard, Günther Rezniczek, Jimmy So, Claus Wilki Fristrup. Second annual report from the ISSPP PIPAC database.Pleura and peritoneum. 2023, 8 (4): 141-146
Charlotte G Kryh-Jensen, Claus W Fristrup, Alan P Ainsworth, Sönke Detlefsen, Michael B Mortensen, Per Pfeiffer, Line S Tarpgaard, Martin Graversen. What is long-term survival in patients with peritoneal metastasis from gastric, pancreatic, or colorectal cancer? A study of patients treated with systemic chemotherapy and pressurized intraperitoneal aerosol chemotherapy (PIPAC).Pleura and peritoneum. 2023, 8 (4): 147-155
Peter Kyle, Kitrick Perry, Anne Moutadjer, Nicholas Gilfillan, Rosalind Webb, Dolan Basak, Paul Ziprin, Dominic Blunt, James Burn, Katherine Van Ree, Antoni Sergot, Jamie Murphy. UK trial of pressurised intraperitoneal aerosolised chemotherapy (PIPAC) with oxaliplatin for colorectal cancer peritoneal metastases (NCT03868228).Pleura and peritoneum. 2023, 8 (4): 157-165
Rogini Balachandran, Mette Møller Sørensen, Jonas Amstrup Funder, Anders Riegels Knudsen, Lene Hjerrild Iversen. Outcomes after curatively intended treatment of limited peritoneal metastases and thermal ablation for liver metastases from colorectal cancer.Pleura and peritoneum. 2023, 8 (4): 167-174
Sage A Vincent, Meghan Maceyko, Peter J Altshuler, Zachary Davis, J Ryan Mark, Paul H Chung, Wilbur B Bowne. Genital cutaneous necrosis: a delayed sequela of intraperitoneal Mitomycin-c.Pleura and peritoneum. 2023, 8 (4): 175-176
Akash Kartik, Catharina Müller, Miklos Acs, Pompiliu Piso, Patrick Starlinger, Thomas Bachleitner-Hofmann, Travis E Grotz. Early postoperative CRP predicts major complications following cytoreductive surgery (CRS) and hyperthermic intraperitoneal chemotherapy (HIPEC).Pleura and peritoneum. 2023, 8 (3): 113-121
Charif Khaled, Antoine El Asmar, Omar Raisi, Michel Moreau, Laura Polastro, Isabelle Veys, Florin C Pop, Vincent Donckier, Gabriel Liberale. Prognostic value of preoperative serological biomarkers in patients undergoing cytoreductive surgery for ovarian cancer peritoneal metastases.Pleura and peritoneum. 2023, 8 (3): 133-138
Anne-Cecile Ezanno, Brice Malgras, Marc Pocard. Pressurized intraperitoneal aerosol chemotherapy, reasons for interrupting treatment: a systematic review of the literature.Pleura and peritoneum. 2023, 8 (2): 45-53
Janina Baake, Giorgi Nadiradze, Rami Archid, Alfred Königsrainer, Hans Bösmüller, Marc Reymond, Wiebke Solass. Peritoneal regression grading score (PRGS): first evidence for independent predictive and prognostic significance.Pleura and peritoneum. 2023, 8 (2): 55-63
Lorena Martín-Román, Enda Hannan, Mohammad Faraz Khan, Anna Sophia Müller, Conor Shields, John Aird, Brendan Moran, Jurgen Mulsow. Correlation between PSOGI pathological classification and survival outcomes of patients with pseudomyxoma peritonei treated using cytoreductive surgery and HIPEC: national referral centre experience and literature review.Pleura and peritoneum. 2023, 8 (2): 65-74
Mélina Deban, Julien Châtelain, François Fasquelle, Daniel Clerc, Laura Toussaint, Martin Hübner, Hugo Teixeira Farinha. The role of cytology in patients undergoing pressurized intraperitoneal aerosol chemotherapy (PIPAC) treatment for peritoneal carcinomatosis.Pleura and peritoneum. 2023, 8 (2): 75-81
Ernest Cheng, Raphael Shamavonian, Jasmine Mui, Raymond Hayler, Josh Karpes, Ruwanthi Wijayawardana, Shoma Barat, Nima Ahmadi, David L Morris. Overall survival and morbidity are not associated with advanced age for cytoreductive surgery and hyperthermic intraperitoneal chemotherapy: a single centre experience.Pleura and peritoneum. 2023, 8 (2): 83-90